Nov. 2 at 2:20 AM
$MASI "Heads up alert! Only three days until Upcoming earnings on Tuesday, 11/4/2025 for
$MASI
Neutral (5.5)
---
Masimo Corporation (NASDAQ: MASI) presents a mixed investment narrative as the company prepares to release its third-quarter financial results on November 4, 2025.
Recent performance metrics indicate that Masimo has faced challenges, with shares declining approximately 14.2% year-to-date and a trailing P/E ratio of 75.96, suggesting a premium valuation relative to earnings.
Despite these pressures, analysts are starting to show renewed optimism, as evidenced by upward revisions in earnings estimates, with four analysts increasing their forecasts.
The company is also recognized for its growth potential, highlighted by its recent upgrade to a Zacks Rank #1 (Strong Buy).
Key financial indicators such as EPS growth and revenue forecasts are being positively revised, suggesting a potential turnaround.
Furthermore, Masimo's strategic divestment of its consumer audio business to HARMAN has sharpened its focus on healthcare, which could enhance operational margins and free up capital for reinvestment in core areas.
In terms of sector performance, the medical technology industry has exhibited resilience, although it has lagged behind broader market indices, with healthcare stocks collectively gaining only 6.5% over the past six months compared to the S&P 500's 24.7% rise.
This underperformance reflects the sector's ongoing struggles with inventory destocking and competitive pressures.
However, with Masimo's innovative technologies and recent strategic moves, the company may be well-positioned to capitalize on upcoming market opportunities, particularly as it prepares for its earnings report, which could serve as a catalyst for stock movement.
Analysts are closely monitoring the options market, indicating heightened expectations for significant price volatility, which could reflect investor sentiment ahead of the earnings announcement.
- Funds were net buyers of
$MASI during the previous reporting quarter.
- Funds with large holdings in
$MASI include:
- Holocene Advisors LP, MV:
$209MM. Fund Rank: 84%
www.holoceneadvisors.com
- Westfield Capital Management Company LP, MV:
$199MM. Fund Rank: 84%
www.westfieldcapital.com
- Alyeska Investments, MV:
$191MM. Fund Rank: 79%
- Viking Global Investors LP, MV:
$129MM. New position. Fund Rank: 70%
www.vikingglobal.com
- RTW Investments LP, MV:
$115MM. Fund Rank: 74%
www.rtwfunds.com
- Last 10 days performance: -4%
- Last 30 days performance: -4%
- Last 90 days performance: -9%
Some of the latest news articles:
- Title: 1 Unprofitable Stock with Exciting Potential and 2 We Brush Off
Publication Date: 10/31/2025 4:42:27 AM, Source: yahoo
URL: https://finance.yahoo.com/news/1-unprofitable-stock-exciting-potential-044227056.html?.tsrc=rss
- Title: Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4
Publication Date: 10/21/2025 1:00:00 PM, Source: yahoo
URL: https://finance.yahoo.com/news/masimo-report-third-quarter-2025-130000546.html?.tsrc=rss
- Title: Here's Why Masimo (MASI) is a Strong Growth Stock
Publication Date: 10/20/2025 1:45:03 PM, Source: yahoo
URL: https://finance.yahoo.com/news/heres-why-masimo-masi-strong-134503769.html?.tsrc=rss
- Title: Merit Medical Expands GI Portfolio With
$22M C2 CryoBalloon Acquisition
Publication Date: 10/16/2025 12:57:00 PM, Source: yahoo
URL: https://finance.yahoo.com/news/merit-medical-expands-gi-portfolio-125700695.html?.tsrc=rss
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal."
